235 related articles for article (PubMed ID: 31131410)
21. Control of scabies and secondary impetigo: optimising treatment effectiveness in endemic settings.
Chosidow O; Hay RJ
Lancet Infect Dis; 2019 May; 19(5):454-456. PubMed ID: 30956112
[No Abstract] [Full Text] [Related]
22. Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.
Marks M; Gwyn S; Toloka H; Kositz C; Asugeni J; Asugeni R; Diau J; Kaldor JM; Romani L; Redman-MacLaren M; MacLaren D; Solomon AW; Mabey DCW; Steer AC; Martin D
Clin Infect Dis; 2020 Dec; 71(12):3226-3228. PubMed ID: 32421762
[TBL] [Abstract][Full Text] [Related]
23. Mass Drug Administration for Scabies - 2 Years of Follow-up.
Romani L; Whitfeld MJ; Koroivueta J; Kama M; Wand H; Tikoduadua L; Tuicakau M; Koroi A; Andrews RM; Kaldor JM; Steer AC
N Engl J Med; 2019 Jul; 381(2):186-187. PubMed ID: 31242358
[No Abstract] [Full Text] [Related]
24. Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community.
Kearns TM; Speare R; Cheng AC; McCarthy J; Carapetis JR; Holt DC; Currie BJ; Page W; Shield J; Gundjirryirr R; Bundhala L; Mulholland E; Chatfield M; Andrews RM
PLoS Negl Trop Dis; 2015 Oct; 9(10):e0004151. PubMed ID: 26516764
[TBL] [Abstract][Full Text] [Related]
25. Community perspectives on scabies, impetigo and mass drug administration in Fiji: A qualitative study.
Mitchell E; Bell S; Thean LJ; Sahukhan A; Kama M; Koroivueti A; Kaldor J; Steer A; Romani L
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008825. PubMed ID: 33275592
[TBL] [Abstract][Full Text] [Related]
26. The Epidemiology of Scabies and Impetigo in Relation to Demographic and Residential Characteristics: Baseline Findings from the Skin Health Intervention Fiji Trial.
Romani L; Whitfeld MJ; Koroivueta J; Kama M; Wand H; Tikoduadua L; Tuicakau M; Koroi A; Ritova R; Andrews R; Kaldor JM; Steer AC
Am J Trop Med Hyg; 2017 Sep; 97(3):845-850. PubMed ID: 28722612
[TBL] [Abstract][Full Text] [Related]
27. High burden of impetigo and scabies in a tropical country.
Steer AC; Jenney AW; Kado J; Batzloff MR; La Vincente S; Waqatakirewa L; Mulholland EK; Carapetis JR
PLoS Negl Trop Dis; 2009 Jun; 3(6):e467. PubMed ID: 19547749
[TBL] [Abstract][Full Text] [Related]
28. Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020.
Thean LJ; Romani L; Engelman D; Wand H; Jenney A; Mani J; Paka J; Cua T; Taole S; Silai M; Ashwini K; Sahukhan A; Kama M; Tuicakau M; Kado J; Parnaby M; Carvalho N; Whitfeld M; Kaldor J; Steer AC
Lancet Reg Health West Pac; 2022 May; 22():100433. PubMed ID: 35345391
[TBL] [Abstract][Full Text] [Related]
29. No secondary impact of ivermectin mass drug administration for onchocerciasis elimination on the prevalence of scabies in northwestern Ethiopia.
Yirgu R; Middleton J; Fekadu A; Davey G; Bremner S; Jones CI; Cassell JA
Trans R Soc Trop Med Hyg; 2024 Feb; 118(2):110-117. PubMed ID: 37665766
[TBL] [Abstract][Full Text] [Related]
30. Incidental mosquitocidal effect of an ivermectin mass drug administration on Anopheles farauti conducted for scabies control in the Solomon Islands.
Kositz C; Talina J; Diau J; Asugeni R; Whitehorn C; Mabey D; Chaccour C; Marks M
Trans R Soc Trop Med Hyg; 2017 Mar; 111(3):97-101. PubMed ID: 28549173
[TBL] [Abstract][Full Text] [Related]
31. Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018-2019.
Willis GA; Kearns T; Mayfield HJ; Sheridan S; Thomsen R; Naseri T; David MC; Engelman D; Steer AC; Graves PM; Lau CL
PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011549. PubMed ID: 37607196
[TBL] [Abstract][Full Text] [Related]
32. Scabies and impetigo prevalence and risk factors in Fiji: a national survey.
Romani L; Koroivueta J; Steer AC; Kama M; Kaldor JM; Wand H; Hamid M; Whitfeld MJ
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003452. PubMed ID: 25738499
[TBL] [Abstract][Full Text] [Related]
33. Scabies and impetigo in Timor-Leste: A school screening study in two districts.
Korte LM; Bowen AC; Draper ADK; Davis K; Steel A; Teodora I; Mascarenhas I; Dingle B; Francis JR
PLoS Negl Trop Dis; 2018 May; 12(5):e0006400. PubMed ID: 29852002
[TBL] [Abstract][Full Text] [Related]
34. Effects of ivermectin mass drug administration for malaria vector control on ectoparasites and soil-transmitted helminths: a cluster randomized trial.
Kositz C; Drammeh M; Vasileva H; Houghton J; Ashall J; D'Alessandro U; Marks M; Bradley J
Int J Infect Dis; 2022 Dec; 125():258-264. PubMed ID: 36336245
[TBL] [Abstract][Full Text] [Related]
35. The Importance of Scabies Coinfection in the Treatment Considerations for Impetigo.
Tasani M; Tong SY; Andrews RM; Holt DC; Currie BJ; Carapetis JR; Bowen AC
Pediatr Infect Dis J; 2016 Apr; 35(4):374-8. PubMed ID: 26599569
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of scabies and impetigo worldwide: a systematic review.
Romani L; Steer AC; Whitfeld MJ; Kaldor JM
Lancet Infect Dis; 2015 Aug; 15(8):960-7. PubMed ID: 26088526
[TBL] [Abstract][Full Text] [Related]
37. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin.
Lawrence G; Leafasia J; Sheridan J; Hills S; Wate J; Wate C; Montgomery J; Pandeya N; Purdie D
Bull World Health Organ; 2005 Jan; 83(1):34-42. PubMed ID: 15682247
[TBL] [Abstract][Full Text] [Related]
38. The microbiology of impetigo in indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus, scabies, and nasal carriage.
Bowen AC; Tong SY; Chatfield MD; Carapetis JR
BMC Infect Dis; 2014 Dec; 14():727. PubMed ID: 25551178
[TBL] [Abstract][Full Text] [Related]
39. The diagnosis of scabies by non-expert examiners: A study of diagnostic accuracy.
Osti MH; Sokana O; Gorae C; Whitfeld MJ; Steer AC; Engelman D
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007635. PubMed ID: 31425513
[TBL] [Abstract][Full Text] [Related]
40. Scabies community prevalence and mass drug administration in two Fijian villages.
Haar K; Romani L; Filimone R; Kishore K; Tuicakau M; Koroivueta J; Kaldor JM; Wand H; Steer A; Whitfeld M
Int J Dermatol; 2014 Jun; 53(6):739-45. PubMed ID: 24168177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
